INSM FY 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$188M+14.6% YoY

Gross Profit

$144M76.6% margin

Operating Income

-$375M-199.0% margin

Net Income

-$435M-230.6% margin

EPS (Diluted)

$-3.88

Cash Flow

Operating Cash Flow

-$363M

Free Cash Flow

-$371M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$833M

Stockholders' Equity

$410M

Cash & Equivalents

$717M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$188M	$164M	+14.6%
Gross Profit	$144M	$125M	+15.9%
Operating Income	-$375M	-$265M	-41.4%
Net Income	-$435M	-$294M	-47.8%